Get the Stockscreener App
15.17
3.56%
-0.56
After Hours:
15.17
Surgery Partners Inc stock is traded at $15.17, with a volume of 1.61M.
It is down -3.56% in the last 24 hours and down -4.11% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$15.73
Open:
$15.87
24h Volume:
1.61M
Relative Volume:
1.10
Market Cap:
$1.98B
Revenue:
$3.34B
Net Income/Loss:
$97.10M
P/E Ratio:
-25.50
EPS:
-0.595
Net Cash Flow:
$208.00M
1W Performance:
-5.36%
1M Performance:
-4.11%
6M Performance:
-0.85%
1Y Performance:
-28.65%
1-Day Range:
$15.16
$15.98
1-Week Range:
$14.87
$16.60
52-Week Range:
$11.41
$24.10
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
15.17 | 2.06B | 3.34B | 97.10M | 208.00M | -0.595 |
HCA
Hca Healthcare Inc
|
389.62 | 84.78B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
243.36 | 20.09B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
236.31 | 15.11B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.87 | 13.21B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
113.88 | 11.20B | 6.07B | 793.80M | 464.40M | 5.9914 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Daily Brief Health Care: Apnimed, Chugai Pharmaceutical, Equifax Inc, Royalty Pharma , Startline, Surgery Partners, Teva Pharmaceutical Sp Adr, Thermo Fisher Scientific Inc and more - Smartkarma
Intermountain acquires 2 Idaho hospitals from Surgery Partners - Healthcare Dive
Should Surgery Partners’ Reaffirmed 2026 Revenue Outlook Require Action From Surgery Partners (SGRY) Investors? - simplywall.st
SGRY|Surgery Partners Inc|Price:15.730|Chg%:+0.510 - TradingKey
Surgery Partners Inc (SGRY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Surgery Partners Inc (SGRY) Institutional Confidence - TradingKey
Surgery Partners Inc (SGRY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Surgery Partners, Inc. Revenue Breakdown – MUN:1SP - TradingView
Why is Surgery Partners stock rallying today? - Investing.com
Why is Surgery Partners stock rallying today? By Investing.com - Investing.com Canada
Surgery Partners Stake Sale Values Idaho Hospitals At $1.2B - Law360
Why Is Surgery Partners Stock Gaining Friday?Surgery Partners (NASDAQ:SGRY) - Benzinga
Intermountain Health Care, Inc. entered into a definitive agreement to acquire remaining majority stake in Idaho Falls Community Hospital, LLC from Surgery Partners, Inc.. - marketscreener.com
Intermountain to buy Surgery Partners’ stakes in 2 Idaho hospitals - Modern Healthcare
Surgery Partners jumps on $1.15B hospital sale deal - Investing.com
Surgery Partners to sell Idaho hospitals to Intermountain Health By Investing.com - Investing.com Nigeria
Surgery Partners, Inc. Reaffirms Earnings Guidance for the Year 2026 - marketscreener.com
Surgery Partners Secures Binding Escrow Agreement for $1.15 Billion Sale of Idaho Hospitals to Intermountain Health - Kalkine Media
Surgery Partners Announces Idaho Falls Hospital Divestiture Agreement - TipRanks
Surgery Partners to sell Idaho hospitals to Intermountain Health - Investing.com
Surgery Partners announces $1.15B deal to sell stakes in Idaho Falls Facilities - Seeking Alpha
Surgery Partners Announces Agreement to Sell Idaho Falls Hospital Interests to Intermountain Health for $795 Million - Quiver Quantitative
Surgery Partners (SGRY) plans $1.15B Idaho Falls hospital sale to Intermountain - Stock Titan
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction - Yahoo Finance
Avoiding Lag: Real-Time Signals in (SGRY) Movement - Stock Traders Daily
1 Healthcare Stock to Target This Week and 2 We Brush Off - Yahoo Finance
Premier Plastic Surgery Partners Introduces Revolutionary Junera™ Regenerative Skin Treatment Across Partner Practices - Yahoo Finance
Form 4 Surgery Partners Inc For: 14 July By Investing.com - Investing.com Nigeria
Surgery Partners (SGRY) director receives 34,364 restricted stock awards - Stock Titan
PREMIER PLASTIC SURGERY PARTNERS APPOINTS HUGH O'NEILL TO LEAD CORPORATE DEVELOPMENT - PR Newswire
Mizuho Securities Sticks to Their Buy Rating for Surgery Partners (SGRY) - The Globe and Mail
Mizuho Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $19 - Moomoo
Surgery Partners (SGRY) Could Be 9% Undervalued As Outpatient Surgery Growth Narrative Builds - Yahoo Finance
Surgery Partners Inc. (SGRY) Q1 2026 Earnings: EPS Surprises to the Upside with 74.79% BeatInvestor Earnings Call - dars.gov.et
Beyond the hospital walls: Why USPI is becoming Tenet's growth engine - MSN
Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain - Yahoo Finance
Surgery Partners focuses on specialty care as investors watch US healthcare trends - Ad-hoc-news.de
Surgery Partners | 4: Statement of changes in beneficial ownership of securities-Officer Doherty David T - Moomoo
Surgery Partners (SGRY) Edges Lower Near Support as Consolidation ContinuesUpthrust Pattern - DonanımHaber
Enterprise value to EBITDA forward of Surgery Partners, Inc. – NASDAQ:SGRY - TradingView
Enterprise value to EBITDA forward of Surgery Partners, Inc. – DUS:1SP - TradingView
Price to earnings forward of Surgery Partners, Inc. – NASDAQ:SGRY - TradingView
SGRYSurgery Partners Inc Latest SEC Filings - Finviz
Why Surgery Partners (SGRY) Stock Is Trading Up Today - Yahoo Finance
Surgery Partners stock rating maintained at Overweight by Cantor - Investing.com Nigeria
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com
Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz - The National Law Review
Price to book forward of Surgery Partners, Inc. – NASDAQ:SGRY - TradingView
Enterprise value to revenue forward of Surgery Partners, Inc. – NASDAQ:SGRY - TradingView
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):